Who should not receive gadopentetate?

Gadopentetate dimeglumine should be used cautiously by women who are pregnant or breastfeeding. It is not known what effect gadopentetate has on a fetus, or if it is passed to a nursing infant through breast milk. Children under two years of age should not be administered gadopentetate, because studies have not been conducted with this subgroup. If you have a history of reactions to certain medications, gadopentetate might not be right for you. Tell your doctor about any reactions to medications you have had in the past and about all medications, both prescription and over-the-counter, that you are currently taking. Certain medical conditions may limit your ability to use gadopentetate during an MRI. They include: a recent brain or head injury, seizure disorder, sickle cell anemia, hemolytic anemia, asthma and allergies. A history of stroke, blood clots or circulation problems could also preclude the use of gadopentetate. If you have acute or chronic renal insufficiency that is severe, hepatorenal syndrome or are post-liver transplant, you should not receive gadopentetate. There is an increased risk of developing nephrogenic systemic fibrosis (NSF). Additionally, if you are already receiving dialysis, gadopentetate may lead to acute renal failure.

Continue Learning about Diagnostic Agent

Important: This content reflects information from various individuals and organizations and may offer alternative or opposing points of view. It should not be used for medical advice, diagnosis or treatment. As always, you should consult with your healthcare provider about your specific health needs.